Risk and special populations

Version vom 12. Juni 2020, 15:15 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

which risk factors make covid worse/better/no effect

RSP - identifying risk factors

which characteristics has covid in a diseased patient with underlying disorder/state

RSP - Pregnancy, Neonatology

RSP - On RAS drugs

RSP - Kidney disease

RSP - any transplantation

RSP - any on biologicals

identifying factors Frailty
32268300 2020. Biomarkers of biological age as predictors of COVID-19 disease severity
32339960 2020. Clinical characteristics of older patients infected with COVID-19: A descriptive study
32331795 ä. Afectacion clinica y sintomatoligica en pacientes mayores de 65 anos por COVID-19
32269670 2020. Canadian Geriatrics Society COVID-19 Recommendations for Older Adults What Do Older Adults Need To Know?

Comorbidity Diabetes, Obesity, low androgens
32249357 ä. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

• [1]

32345580 2020. Diabetes and covid-19: a global health challenge
32345579 2020. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes

Heart
32331955 ä. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis
32326691 2020. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction
32277299 2020. Perspective: cardiovascular disease and the Covid-19 pandemic

32335068 ä. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock

Cancer
32278878 ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak
32345594 2020. Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak

HIV
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19

other pharmacology

• ACEI/AT1RA not risky ?
• dextrometorphan (antitussive compd)

Drug abuse
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19

modifiable - tobacco
32303807 ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic

indoor livin ppl

• no sunlight no vitamin d

Psychiatry
32294689 2020. Schizophrenia and COVID-19: risks and recommendations

32371563 2020. Asthma increases risk of severity of COVID-19

32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

32271368 ä. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission
32270178 ä. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV
32353114 ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?

32161990 ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
32328736 ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity

32357998 2020. Cardiac considerations in patients with COVID-19
32332038 2020. Asthma and COVID-19

32350632 2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty

32300516 ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times

32298981 2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
32334395 ä. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia ? A systematic review, meta-analysis, and meta-regression?
32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease

32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?

32328575 ä. Age, frailty and diabetes ? triple jeopardy for vulnerability to COVID-19 infection
32322805 ä. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV

32134381 2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China

32305831 ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment

32232395 ä. Initial COVID-19 affecting cardiac patients in China

32344292 2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors

32322046 ä. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China
32296994 ä. The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments
C7141546 ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32345527 ä. Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence

32269089 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19

32341104 2020. Cardiovascular comorbidity and its impact on patients with Covid-19
32350104 ä. COVID-19 and Nicotine as a Mediator of ACE-2
32341101 2020. COVID-19 and Smoking Is Nicotine the Hidden Link?
32312864 ä. Association between ages and clinical characteristics and outcomes of coronavirus disease 2019

32284245 ä. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is ?Safe Better than Sorry??

32222253 2020. COVID-19: lessons from the Italian reproductive medical experience

32323577 ä. What the oncologist needs to know about COVID-19 infection in cancer patients

32357575 2020. COVID-19: A Geriatric Emergency
32357582 2020. Ageing and COVID-19: What is the Role for Elderly People?
32274617 2020. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
32199996 2020. Infection par le SARS-CoV-2 chez les femmes enceintes: etat des connaissances et proposition de prise en charge par CNGOF
32244059 ä. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes
32302703 ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
32292696 ä. COVID-19 Infection Unmasking Brugada Syndrome

32325028 ä. G6PD deficiency in COVID-19 pandemic: ?a ghost in the ghost?

32342146 ä. COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?

32146921 ä. COVID-19 and gender-specific difference: Analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020

32307025 ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?

32335339 ä. Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count

32331343 2020. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D

32355869 ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?

32297089 ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients

32333915 ä. Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2

32371047 ä. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic

32224277 2020. COVID-19 and immunomodulator/immunosuppressant use in dermatology
32199889 2020. Should biologics for psoriasis be interrupted in the era of COVID-19?
32283234 ä. Biologics for psoriasis during COVID-19 outbreak
32246966 ä. COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution

32305444 ä. COVID-19 and racial disparities
32283235 ä. Various forms of skin rash in COVID-19 : a reply
32283233 ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection

32330545 ä. African American COVID-19 Mortality: A Sentinel Event

32154911 2020. COVID?19 Presents High Risk to Older Persons

32347144 2020. Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors
32253068 2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy

32370269 2020. Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?
32244852 2020. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)

32222956 ä. Prevalence and impact of diabetes among people infected with SARS-CoV-2

32300796 ä. A geroscience perspective on COVID-19 mortality
32279081 ä. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study
32360995 ä. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease
32278005 ä. Non-alcoholic fatty liver diseases in patients with COVID-19: A etrospective study
32348791 ä. Clinical characteristics of COVID-19 patients with abnormal liver tests
32348790 ä. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
32305291 ä. Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury

32240670 2020. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
32171866 ä. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

32147409 ä. Are children less susceptible to COVID-19?

32366317 2020. Covid-19?The real role of NSAIDs in Italy

32306369 ä. The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities

32335513 2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis

32373791 ä. Sex Differences in Mortality from COVID-19 Pandemic: Are Men Vulnerable and Women Protected?

{{tp|p=32302293|t=2020. COVID-19 in older adults: clinical, psychosocial, and public health considerations |pdf=|usr=}

32278370 2020. The gendered dimensions of COVID-19
32334645 2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
32359411 ä. COVID-19 and obesity?lack of clarity, guidance, and implications for care

32171057 2020. Implications of COVID-19 for patients with pre-existing digestive diseases
32304642 ä. COVID-19 in patients with HIV: clinical case series

32224304 2020. COVID-19 infection in children

32171067 2020. Sex difference and smoking predisposition in patients with COVID-19
32171062 2020. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
32332856 ä. COVID-19 in persons with haematological cancers
32353398 ä. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China
32344304 ä. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ?
32339776 2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease

32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan

32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China

32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?

32283004 ä. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology

32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

32327737 ä. Obesity and impaired metabolic health in patients with COVID-19

32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19

32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan

32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China

32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology

32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

32327737 ä. Obesity and impaired metabolic health in patients with COVID-19
32203970 ä. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade
32311696 ä. Comment on ?Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade?
32371550 2020. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19

32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan

32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China

32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China

32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?

32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

32327737 ä. Obesity and impaired metabolic health in patients with COVID-19

32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epilepticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19

32372822 2020. Why are ethnic minorities worse affected?
32372818 2020. Men hit harder by covid-19
32372803 2020. Children and covid-19
32243722 2020. Lessons unfolding from pediatric cases of COVID?19 disease caused by SARS?CoV?2 infection

32360482 2020. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?

32343745 2020. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients

32231171 2020. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis

32343807 ä. The Elderly & COVID-19: Cocooning or Culling: - the choice is ours

32289171 ä. Cardiac drugs and outcome in COVID-19: Reply
32289168 ä. Cardiac drugs and outcome in COVID - 19

C7129713 ä. Coronavirus: la emergencia geri�trica de 2020 Documento conjunto de la Secci�n de Cardiolog�a Geri�trica de la Sociedad Espa�ola de Cardiolog�a y la Sociedad Espa�ola de Geriatr�a y Gerontolog�a

32331829 ä. Smoking and coronavirus disease 2019 (COVID-19)

32336968 2020. COVID-19 outbreak impact in Spain: A role for tobacco smoking?
32206052 2020. COVID-19 and smoking: A systematic review of the evidence
32355638 ä. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system

32377677 ä. COVID-19 in Older People: A Rapid Clinical Review

32228252 2020. COVID-19, ACE2, and the cardiovascular consequences

32212348 2020. Why is COVID-19 so mild in children?
32339307 2020. Additional hypotheses about why COVID-19 is milder in children than adults
32279351 2020. We urgently need guidelines for managing COVID-19 in children with comorbidities
32310898 2020. Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome

32358994 2020. Asthma and COVID-19: is asthma a risk factor for severe outcomes?
32311145 2020. SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience
32243621 2020. COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient
32267016 2020. Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)

32329629 2020. Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2

32339251 2020. The importance of hypertension as a risk factor for severe illness and mortality in COVID-19

32243894 2020. COVID-19 infection in cancer patients: early observations and unanswered questions
32224151 2020. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
32321720 2020. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)

32245656 2020. COVID-19 in patients with cardiovascular diseases üüüüüüü
32255510 2020. COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement
32369656 2020. Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding
32219995 2020. Safe delivery for pregnancies affected by COVID-19
32339382 2020. Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis
32324956 2020. How should we treat pregnant women infected with SARS-CoV-2?
32340018 2020. Coronavirus Disease 2019 in a Hemodialysis Patient
32220865 2020. Non-steroidal anti-inflammatory drugs and covid-19
32205306 2020. Covid-19: European drugs agency to review safety of ibuprofen
32184201 2020. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
32253225 2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases
32369736 ä. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
32241880 2020. Drugs and the renin-angiotensin system in covid-19
32291262 2020. Covid-19: Black people and other minorities are hardest hit in US
32379903 2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2
32369615 2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
32369606 2020. COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience
32314798 2020. COVID-19 infection in patients with sickle cell disease
32333398 2020. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance
32312714 2020. COVID-19 More Frequent, Severe in Cancer Patients
32352633 2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients
32302248 2020. ACEing COVID-19: A Role For Angiotensin Axis Inhibition in SARS-CoV-2 infection?
32302265 2020. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19

32339025 2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend

32377468 ä. First Case of an Infant with COVID-19 in the Middle East
32320270 2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
32282224 2020. COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations
32345646 2020. BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte)
32286246 2020. COVID-19 infections are also affected by human ACE1 D/I polymorphism
32112082 2020. A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load
32220930 2020. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19
32342637 2020. COVID-19 and obesity
32292054 2020. SARS-CoV-2 Infection in a 2-Week-Old Male With Neutropenia
32255491 2020. ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19
32320478 2020. Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence
32237261 ä. The COVID?19 outbreak and rheumatologic skin diseases
32259878 ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?
32375909 ä. Impact of Fundamental Diseases on Patients With COVID-19
32129518 ä. Angiotensin receptor blockers as tentative SARS?CoV?2 therapeutics
32233013 ä. Diabetes is a risk factor for the progression and prognosis of COVID?19
32374012 2020. Mortality rate and gender differences in COVID-19 patients dying in Italy: A comparison with other countries
32189428 ä. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID?19 in the general population?
32376408 ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study
32369240 2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind
32367558 2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?
32356577 2020. Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration
32359088 2020. RAAS blockers in hypertension posing a higher risk towards the COVID-19
32362061 2020. (pat.on)Dupilumab and COVID-19: What should we expect?
32259611 2020. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
32356926 2020. Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19
32304146 2020. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections
32329083 2020. (ang.)COVID-19 transmission through host cell directed network of GPCR
32234728 2020. EMA advice on the use of NSAIDs for Covid-19
32295811 2020. EMA advice on renin-angiotensin system medicines during covid-19 pandemic
32357072 2020. CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA
32376075 2020. Oligohydramnion in COVID19
32290680 2020. Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers
32310915 2020. ACE-inibitori, sartani e sindrome respiratoria acuta da coronavirus 2
32354990 2020. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
32239590 ä. Clinical findings in a patient with haemophilia A affected by COVID?19
32362297 ä. Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox

32376422 ä. Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern
32380214 ä. Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic
32245909 2020. A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis
32312788 2020. Covid-19 infection in Crohn s disease under treatment with adalimumab
32307955 2020. COVID-19, THE KIDNEY AND HYPERTENSION
32220017 2020. Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient
32340044 2020. The ACE-2 in COVID-19: Foe or Friend?
32208987 2020. Renin-angiotensin system (RAS) blockers and the COVID-19 pandemic: at present there is no evidence to abandon RAS blockers
32367746 2020. ACE2, COVID-19, and ACE Inhibitor and ARB Use during the Pandemic: The Pediatric Perspective
32348166 2020. Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study
32324897 2020. Management of the first patient with confirmed COVID-19 in pregnancy in India: From guidelines to frontlines
32330287 2020. A systematic scoping review of COVID-19 during pregnancy and childbirth
32270479 2020. Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia
32271947 2020. Delivery in pregnant women infected with SARS-CoV-2: A fast review
32369616 2020. Critically ill pregnant patient with COVID-19 and neonatal death within two hours of birth
32310015 2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature
32255507 2020. COVID-19 and Older Adults: What We Know
32301766 ä. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2
32376098 ä. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS
32371817 2020. Angiotensin-converting enzyme-2 in SARS-CoV-2 infection: good or bad?
32371814 2020. Response to four comments on ?Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic??
32371812 2020. COVID-19, hypertension and angiotensin receptor-blocking drugs
32371810 2020. Comment on ?Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic??
32345701 2020. The Immunocompromised Transplant Recipient and SARS-CoV-2 Infection
32317402 2020. Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York
32312797 2020. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?
32253888 2020. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection
32351121 2020. Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder
32353193 2020. Is the type of diabetes treatment relevant to outcome of COVID-19?
32162476 2020. Diabetes and COVID-19
32379925 2020. Improvement of SARS-CoV2 symptoms following Guselkumab injection in a psoriatic patient
32379913 2020. Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs
32358791 2020. SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor
32330323 2020. Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports
32294258 2020. SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor
32195824 2020. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
32242993 2020. Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk
32354293 2020. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review

32222119 ä. Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia
32220066 ä. SARS?CoV?2 and HIV
32115733 ä. Coronavirus disease (COVID?19) and neonate: What neonatologist need to know
32160316 ä. Co?infection of SARS?CoV?2 and HIV in a patient in Wuhan city, China
32248565 ä. A twin challenge to handle: COVID?19 with pregnancy
32374416 2020. ACE2 and prognosis of COVID-19 Insights from Bartter s and Gitelman s syndromes patients
32369211 2020. What could be the better choice between ACE inhibitors and AT1R antagonists in coronavirus disease 2019 (COVID-19) patients?
32369203 2020. Smoking links to the severity of Covid-19: An update of a meta-analysis
32221983 2020. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
32266994 2020. Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19"
32266993 2020. Reporting of all cardiac medications and their outcome in COVID - 19
32352576 2020. COVID-19 in pregnancy: risk of adverse neonatal outcomes
32347975 2020. HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey
32343410 2020. COVID-19 in Tuberculosis patients: a report of three cases
32330302 2020. Comment on "Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"
32293753 2020. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis
32293709 2020. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better
32285949 2020. Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19)
32374288 2020. Newborns at risk of COVID-19
32243919 2020. A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab

32369097 ä. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
32380044 ä. Obesity could shift severe COVID-19 disease to younger ages
32376099 ä. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
32324209 ä. Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
32242890 2020. Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers
32215598 ä. Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China
32171074 2020. Comorbidities and multi-organ injuries in the treatment of COVID-19
32251625 2020. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
32251539 2020. COVID-19 and liver disease

32329563 2020. Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis
32243068 2020. Breastfeeding and coronavirus disease-2019: Ad interim indications of the Italian Society of Neonatology endorsed by the Union of European Neonatal & Perinatal Societies
32377709 2020. Obesity - a risk factor for increased COVID-19 prevalence, severity and lethality
32320556 ä. Late-Onset Neonatal Sepsis in a Patient with Covid-19
32356627 ä. Renin?Angiotensin?Aldosterone System Blockers and the Risk of Covid-19
32356625 ä. Inhibitors of the Renin?Angiotensin?Aldosterone System and Covid-19
32356628 ä. Renin?Angiotensin?Aldosterone System Inhibitors and Risk of Covid-19
32347572 2020. Outcome of Parkinson s Disease Patients Affected by COVID-19
32242182 2020. A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019)

32281287 2020. Risk of COVID?19 for patients with obesity
32237212 ä. COVID 19 and the Patient with Obesity ? The Editors Speak Out
32332320 ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vertical Transmission in Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) Pneumonia
32250049 ä. COVID?19 infection in a paucisymptomatic infant: Raising the index of suspicion in epidemic settings
32365269 2020. Obesity and severe COVID-19 disease: a strong association
32365275 2020. Obesity accompanying COVID-19: the role of epicardial fat
32352637 2020. Association of Obesity with Disease Severity among Patients with COVID-19
32339391 2020. The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections
32324968 2020. Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?
32314871 2020. Targeting the Adipose Tissue in COVID-19
32314868 2020. Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?
32314861 2020. Obesity is Associated with Severe Forms of COVID-19
32286926 2020. Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?
32319118 2020. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover
32366612 2020. Early Neonatal SARS-CoV-2 Infection Manifesting With Hypoxemia Requiring Respiratory Support
32345686 2020. Vulnerable Youth and the COVID-19 Pandemic
32317311 2020. Mitigating the Impacts of the COVID-19 Pandemic Response on At-Risk Children
32339304 2020. Managing COVID-19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid-sparing Immunosuppression
32234837 2020. COVID-19 and non-communicable diseases
32304114 2020. Preterm delivery in pregnant woman with critical COVID-19 pneumonia and vertical transmission
32377638 2020. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis
32319449 2020. A pregnant woman and the SARS-CoV-2 infection: how are barriers easily crossed?
32374541 2020. Diabete et infection a COVID-19
32348046 2020. Rhumatologie et COVID-19
32348045 2020. Maladies autoimmunes dans le contexte de la pandemie COVID-19
32348044 2020. L'hematologie au temps du COVID-19
32348042 2020. Infection a SARS-CoV-2 et transplantation d'organes solides
32301198 ä. Case report: A kidney transplant patient with mild COVID?19
32160345 ä. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals
32302282 2020. Sex- and Gender-specific Observations and Implications for COVID-19
32364677 2020. COVID-19 pneumonia in kidney transplant recipients-Where we are?
32279418 2020. Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19)
32357273 2020. A catabolic state in a kidney transplant recipient with COVID-19

32266753 2020. Intrauterine vertical transmission of SARS-CoV-2: what we know so far
32349165 2020. Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?
32304612 2020. Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic
32135587 2020. 2019 novel coronavirus infection in a three-month-old baby
32234132 2020. First case of neonate with COVID-19 in China
32268709 2020. Attach importance to COVID-19 infection on maternal and infant outcomes
32145714 2020. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province
32164092 2020. Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia
32340096 2020. Preliminary clinical study of direct renin inhibitor aliskiren in the treatment of severe COVID-19 patients with hypertension
32283876 2020. Scientific statement on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19
32189489 2020. ACE2 in the context of 2019-nCoV infection: friend or foe?

C7197241 2020. ACEI inhibitors and ARBs do not increase severity of COVID-19
C7183935 ä. Status of SARS-CoV-2 infection in patients on renal replacement therapy Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN)?
C7194925 2020. ... COVID-19 para el paciente con insuficiencia cardiaca, trasplante cardiaco y asistencia ventricular ...
C7158793 2020. Neonatal COVID?19: little evidence and the need for more information?
C7169649 2020. EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemic
C7149285 ä. Coronaviruserkrankung 2019 (COVID-19) und Schwangerschaft: Übersicht und Bericht des ersten deutschen Falls mit COVID-19 bei Gestationsdiabetes
C7149289 2020. Regulatory agencies issue advice on use of NSAIDs for COVID-19
C7187739 ä. Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa
32387327 ä. SARS-CoV-2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg
32376317 ä. Evidence for and against vertical transmission for SARS-CoV-2 (COVID-19)
32292902 2020. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a�systematic review and meta-analysis
32430225 ä. Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income
C7164917 ä. COVID 19: SINDROME FEBRIL Y CL�NICA NEUR�LOGICA EN NEONATO

32387167 ä. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019
32387456 ä. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
32402433 ä. Child with liver transplant recovers from COVID-19 infection A case report
32376395 2020. SARS-CoV-2 infection among patients with systemic autoimmune diseases
32376969 ä. COVID-19 outcomes in patients with hematologic disease
32386820 ä. Evidence of mother-to-newborn infection with COVID-19
32381262 ä. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission
32389618 ä. An infant with a mild SARS-CoV-2 infection detected only by anal swabs: a case report
32382516 2020. Severe COVID-19 infection in pregnancy requiring intubation without preterm delivery: A case report

32132140 2020. Proposal for prevention and control of the 2019 novel coronavirus disease in newborn infants
32267499 ä. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease
32377468 ä. First Case of an Infant with COVID-19 in the Middle East
32402515 ä. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis
32413819 2020. Vitamin D concentrations and COVID-19 infection in UK Biobank

32408118 2020. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
32387864 2020. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects
32388171 2020. SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome
32291196 2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32402627 ä. Re: Novel Coronavirus COVID-19 in late pregnancy: Outcomes of first nine cases in an inner city London hospital
32389521 2020. COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience
32409114 ä. Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients

32336767 2020. Erhöhtes Risiko bei COVID-19: Alter, Vorerkrankung, Demenz
32248854 ä. A potential protective role of losartan against coronavirus-induced lung damage
32376408 ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study
C7128941 2020. COVID19 Presents High Risk to Older Persons
32376043 ä. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak
32380288 ä. Genetic susceptibility for COVID-19?associated sudden cardiac death in African Americans
32448641 ä. Bloqueantes del sistema renina-angiotensina e infeccion por COVID-19
32389847 2020. Urgent need for evaluating agonists of angiotensin-(1-7)/Mas receptor axis for treating patients with COVID-19
32294485 ä. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
32439209 ä. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience
32376098 ä. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
32430156 ä. COVID-19 in a pediatric heart transplant recipient: Emergence of donor-specific antibodies
C7165097 2020. COVID-19 pneumonia in a dual heart?kidney recipient

32414646 2020. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
32371279 ä. Therapeutic Strategy for Patients with Coronavirus Disease 2019 During Left Ventricular Assist Device Supports
32305569 2020. Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support
32360010 2020. The Renin-Angiotensin-Aldosterone System in Coronavirus Infection-Current Considerations During the Pandemic
32268149 2020. An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrations
32408961 ä. Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery
32292915 ä. Severe COVID-19 With ARDS in a Patient on Durable LVAD Support
32380044 2020. Obesity could shift severe COVID-19 disease to younger ages
C7202821 2020. COVID-19: underlying metabolic health in the spotlight

32388230 2020. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
32389426 2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ...
32376099 2020. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
32475616 ä. copd w covid....
32360210 2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection
32332868 ä. Mechanisms by which angiotensin-receptor blockers increase ACE2 levels
32387757 2020. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?
32408147 2020. Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
32408155 2020. Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
32388458 2020. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment
32388451 2020. COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach
32388461 2020. Rethinking high-risk groups in COVID-19
32456945 ä. Supresi�n de angiotensina II en la infecci�n por el virus SARS-CoV-2: una propuesta terap�utica
32456944 ä. Alta prevalencia de COVID-19 asintom�tico en hemodi�lisis Aprendiendo d�a a d�a el primer mes de pandemia de COVID-19
32389518 ä. Situaci�n de la infecci�n por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo Informe del Registro COVID-19 de la Sociedad Espa�ola de Nefrolog�a (SEN)
32382684 2020. The mutual effects of COVID-19 and obesity
32389584 ä. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis
32377638 2020. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis
32421537 2020. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)

32292226 ä. Coronavirus: la emergencia geriatrica de 2020...
32418728 ä. Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
32382258 2020. Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis